Related Experiment Video
Updated: Oct 19, 2025

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues
Published on: July 8, 2020
Rutin Exerts Cytotoxic and Senescence-Inducing Properties in Human Melanoma Cells
Iulia Pinzaru1,2, Raul Chioibas3, Iasmina Marcovici1,2
1Research Center for Pharmaco-Toxicological Evaluations, Faculty of Pharmacy, "Victor Babeș" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania.
Abstract:
Malignant melanoma represents the deadliest type of skin cancer with narrow treatment options in advanced stages. Herbal constituents possessing anticancer properties occupy a particular spot in melanoma research as potential chemotherapeutics. Rutin (RUT) is a natural compound exerting antioxidant, antimicrobial, anti-inflammatory, UV-filtering, and SPF-enhancing activities that are beneficial to the skin; however, its effect as an anti-melanoma agent is less investigated. The current study is focused on assessing the cytotoxic potential of RUT against two different human melanoma cell lines: RPMI-7951 and SK-MEL-28 by evaluating its impact in terms of cell viability, cells' morphology, and nuclear aspect assessment, and senescence-inducing properties. The results indicate a dose-dependent decrease in the viability of both cell lines, with calculated IC50 values of 64.49 ± 13.27 µM for RPMI-7951 cells and 47.44 ± 2.41 µM for SK-MEL-28, respectively, accompanied by a visible reduction in the cell confluency and apoptotic features within the cell nuclei. RUT exerted a senescence-inducing property highlighted by the elevated expression of senescent-associated beta-galactosidase (SA-β-gal) in SK-MEL-28 cells. Despite the in vitro anti-melanoma effect revealed by our results, further studies are required to elucidate the mechanisms of RUT-induced cytotoxicity and senescence in melanoma cells.
Insights
Rutin (RUT), a natural compound, shows potential against malignant melanoma by reducing cancer cell viability and inducing senescence. Further research is needed to understand its anti-melanoma mechanisms.
Area of Science:
- Oncology
- Dermatology
- Pharmacology
Background:
- Malignant melanoma is an aggressive skin cancer with limited advanced treatment options.
- Natural compounds are explored for their anticancer properties in melanoma research.
- Rutin (RUT) exhibits various skin-beneficial activities, but its anti-melanoma effects are underexplored.
Purpose of the Study:
- To evaluate the cytotoxic potential of Rutin (RUT) against human melanoma cell lines.
- To assess RUT's impact on cell viability, morphology, nuclear features, and senescence.
- To investigate RUT as a potential natural chemotherapeutic agent for melanoma.
Main Methods:
- In vitro assessment of RUT's cytotoxicity on RPMI-7951 and SK-MEL-28 melanoma cell lines.
- Evaluation of cell viability, morphology, nuclear changes, and senescence induction.
- Determination of IC50 values and expression of senescent-associated beta-galactosidase (SA-β-gal).
Main Results:
- RUT demonstrated a dose-dependent decrease in melanoma cell viability.
- Calculated IC50 values were 64.49 ± 13.27 µM for RPMI-7951 and 47.44 ± 2.41 µM for SK-MEL-28.
- RUT induced apoptotic features and senescence, evidenced by increased SA-β-gal expression in SK-MEL-28 cells.
Conclusions:
- Rutin exhibits in vitro cytotoxic and senescence-inducing effects against human melanoma cells.
- RUT presents potential as a natural agent for melanoma treatment.
- Further studies are necessary to elucidate the precise mechanisms of RUT's anti-melanoma activity.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Replicative Cell Senescence
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
The Intrinsic Apoptotic Pathway
Abnormal Proliferation

